Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Planned for Nov 11, 2026 · Notice filed Nov 12, 2026
A Castle Biosciences officer told the SEC about a plan to sell $112K of Castle Biosciences shares around Nov 11, 2026. The filing says the shares were acquired as compensation. That is a tiny part of all Castle Biosciences shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider selling
Traded Nov 11 · filed 2 days laterNot reported under a pre-arranged trading plan
Castle Biosciences's Chief Commercial Officer sold $112K of Castle Biosciences shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Nov 11 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
